Phototherapy device

Through the removable connection between the surface-shaped optical waveguide components and the light source components, the point light source is converted into a surface light source, solving the problems of large-scale treatment and high cost and environmental pollution in existing phototherapy products, and achieving efficient and hygienic phototherapy product design .

CN118949289APending Publication Date: 2024-11-15SUMMER SPROUT TECHNOLOGY (WUHU) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411302258.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-18
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing phototherapy products are difficult to achieve large-scale treatment and are costly. The integration of light sources and equipment limits their use as disposable products, resulting in environmental pollution and hygiene problems.

Method used

The phototherapy device is used to removably connect the surface optical waveguide components and the light source components. The point light source or line light source is converted into a surface light source through an optical connection structure, and the optical waveguide components can be detached and discarded after use, reducing costs and improving hygiene.

Benefits of technology

The phototherapy product with a highly three-dimensional structure is suitable for large-area treatment, which reduces production costs, avoids environmental pollution and sanitary risks caused by unnecessary discarding of light sources, and improves the hygiene of the product.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118949289A_ABST
    Figure CN118949289A_ABST
Patent Text Reader

Abstract

The invention discloses a phototherapy device which comprises a light source component, an optical waveguide component, at least one optical connection structure and at least one light conduction component, and the optical connection structure is arranged between the light source component and the light conduction component and / or between the light conduction component and the optical waveguide component. The optical connection structure enables the two connected parts to be separable; the optical waveguide member has a planar shape. Large-area treatment can be realized by adopting the planar optical waveguide component, in addition, as the light source component is not integrated on the optical waveguide component, the planar optical waveguide component can realize a highly three-dimensional structure and can be well attached to a to-be-treated part, and in addition, the optical waveguide component and the light source component are detachably connected, so that the light source component is not integrated on the optical waveguide component. The optical waveguide component and the light source component can be separated, and the optical waveguide component can be detached and discarded after use, so that disposable use of the product is realized, and repeated use of the light source component is realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of phototherapy, and in particular relates to a phototherapy device. Background Art

[0002] In the mid-to-late 20th century, technologies such as low light laser treatment and photobiomodulation (PBM) appeared, both of which used light as a means of treating diseases in the medical field (Michael R. Hamblin, Ying-ying Huang, Handbook of Photomedicine, CRC Press). In recent years, many studies have shown that red light to near-infrared light can help promote the regeneration of tissues such as collagen and skin cells, and can be used in anti-wrinkle beauty, promoting wound healing, removing spots and scars, and other fields (Chan Hee Nam et al., Dermatologic Surgery, 2017, 43: 371-380; Daniel Barolet, Semin Cutan Med Surg, 2008, 27: 227-238; Yongmin Jeon, Adv. Mater. Technol. 2018, 1700391). With the rapid development of micro-light therapy and photobiomodulation technology, more and more phototherapy products have emerged, especially wearable phototherapy products, such as phototherapy masks, phototherapy hair growth caps, phototherapy shaping clothes, eye phototherapy devices, etc., which have become the ideal home beauty, body or health care products for more and more people. The light source used in phototherapy products can emit light with a peak wavelength between 400-1400nm, preferably red light and near-infrared light with a peak wavelength between 600-970nm. Light in this band has the effects of anti-wrinkle, skin regeneration, freckle removal, and even anti-inflammatory (such as styes, acne), wound healing, and scar reduction (Daniel Barolet, Semin Cutan Med Surg, 27: 227-238, 2008).

[0003] Phototherapy products on the market generally use two types of light sources, laser and LED. Laser is a coherent light source with high energy, which directly hits subcutaneous cells to achieve therapeutic effects. Laser is a point light source or a line light source, which requires repeated local treatments. At the same time, the high intensity of laser light can easily cause burns, so it is not suitable for large-area treatments. In recent years, LED light sources have been widely used in medical beauty products, such as phototherapy masks and hair growth caps. However, LED is also a point light source and faces the same dilemma of large-area treatment as laser. In order to convert the point light source of LED into a surface light source, it is generally necessary to cover the entire area to be treated in an array. The LED light source has a high light intensity density and is accompanied by a large amount of heat dissipation. Usually, a heat sink component is integrated to help cool down when used, which increases the volume and weight, which is not conducive to use as a component of a wearable medical device. Application CN203694423U and the inventor's previous application CN109173071A mentioned the use of OLED to prepare phototherapy masks; the inventor's previous patent applications CN111481833A, CN111514466A, CN111544774A and CN112754764A respectively mentioned the use of OLED to prepare hair growth caps, phototherapy shaping clothes, phototherapy socks and phototherapy band-aids. Although OLED is an ideal surface light source, its preparation process makes 3D forming difficult, and when used as a phototherapy product for the face, the fit will decrease. On the other hand, medical products are usually discarded after a single use to ensure hygiene and avoid cross infection. If the light source and are also discarded together, it will not only increase the cost but also cause environmental pollution. Therefore, how to form a phototherapy product with a highly three-dimensional structure, suitable for large-area treatment and disposable has become a focus of attention.

[0004] US11458329B2 discloses components and devices for phototherapy delivery, specifically discloses LLLT treatment devices for nasal area surgery, LLLT treatment devices for human hair growth, repair and / or scalp healing, and LLLT treatment devices for leg surgery such as total knee replacement or TKA postoperative care, etc., and discloses corresponding structural schematic diagrams. These devices may include a PBM control module (including a light source) and may include a light guide or light guide device, as shown in the figures on pages 27-38, the light guide or light guide device is in the shape of a pipe, and cannot form a surface light source, but can only form a line light source.

[0005] The inventor's previous patent application CN118490992A discloses a photoelectric device that combines a visible light surface light source with a near-infrared (NIR) point light source or a line light source, specifically, the point light source or the line light source is arranged on the side of the optical waveguide device and the surface light source is arranged below the first surface of the optical waveguide device, thereby achieving optical path coupling with the optical waveguide device. However, the point light source in the application is integrated on the side of the optical waveguide device, the surface light source is integrated on the lower surface of the optical waveguide device, no light-conducting component is used between the light source and the optical waveguide device, the light source cannot be separated from the optical waveguide device, and it is limited to using a high-cost OLED surface light source, which limits its possibility of being used as a disposable product.

[0006] Patent application CN113577568A discloses a light-guiding film and a phototherapy mask including the light-guiding film, wherein the light-guiding film includes a flexible diaphragm and a separator. The flexible diaphragm has a plurality of light-emitting units, each of which includes a light-entering portion, a light-guiding portion, and a light-emitting portion. The separator includes a separator, an optical fiber line embedded in the separator, and a light-emitting terminal connected to the light-entering portion. However, the series of light-emitting units, optical fiber lines, and light-emitting terminals in the application are integrated together and cannot be separated, and each light-emitting unit requires a light-guiding portion, which increases its raw material and preparation costs.

[0007] Patent application US2010 / 0303409A1 discloses a solid-state light source, which includes an optical pump, a waveguide component, and a down converter. The application does not disclose the application of the solid-state light source in the field of phototherapy. At the same time, the optical pump and the optical waveguide component in the application are integrated together and cannot be disassembled. The optical waveguide component in the application is tubular and can only transmit light from one end to the other end, and cannot convert it into a surface light source.

[0008] The present invention realizes a highly three-dimensional structure and large-area treatment by adopting a planar optical waveguide component and detachably connecting the optical waveguide component with a light source component, while greatly reducing the cost so that the product can be used as a disposable product. Summary of the invention

[0009] The present invention aims to provide a phototherapy device to solve at least some of the above problems. The phototherapy device includes a planar optical waveguide component and the optical waveguide component and the light source component are detachably connected, so that a highly three-dimensional structure and large-area treatment can be achieved, while greatly reducing costs, so that the product can be used as a disposable product and can also meet the phototherapy needs of different parts.

[0010] According to one embodiment of the present invention, a phototherapy device is disclosed, comprising:

[0011] An electric drive device, a light source component, an optical waveguide component, at least one optical connection structure, and at least one light conducting component;

[0012] Wherein, the light source component is electrically connected to the electric drive device,

[0013] The light source component is connected to the light transmission component,

[0014] The light-conducting component is connected to the light-waveguide component,

[0015] The optical connection structure is arranged between the light source component and the light transmission component, and / or between the light transmission component and the optical waveguide component, and at least one of the optical connection structures enables the two connected components to be detachably separated;

[0016] The optical waveguide component is planar and has at least one light-emitting surface, the area of ​​which is not less than 5 cm 2 .

[0017] The optical waveguide component used in the phototherapy device disclosed in the present invention is planar and can convert a point light source or a line light source into a planar light source, thereby achieving large-area treatment. In addition, since the light source component is not integrated on the optical waveguide component, the planar optical waveguide component can achieve a highly three-dimensional structure and can fit the part to be treated well. In addition, the optical waveguide component and the light source component of the present invention are detachably connected, which can realize the separation of the optical waveguide component and the light source component. After use, the optical waveguide component can be disassembled and discarded, thereby realizing the disposable use of the product, while the electric drive device and the light source component can be reused, thereby improving the hygiene level, being more suitable for medical use, greatly reducing production costs, and avoiding environmental pollution problems caused by the light source being discarded together. In addition, the optical waveguide component can be arranged on a flexible shell. Since the optical waveguide component and / or the flexible shell can be prepared independently, there is more room for material selection, which can ensure 3D shaping and better fit when worn. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1a It is a schematic structural diagram of a phototherapy device according to a first embodiment of the present invention.

[0019] Figure 1b It is a schematic structural diagram of a phototherapy device according to a second embodiment of the present invention.

[0020] Figure 1c It is a schematic structural diagram of a phototherapy device according to a third embodiment of the present invention.

[0021] Figure 1d It is a schematic structural diagram of a phototherapy device according to a fourth embodiment of the present invention.

[0022] Figure 2a yes Figure 1a A cross-sectional view of the phototherapy device along line AA'.

[0023] Figure 2b yes Figure 1b Cross-sectional view of the phototherapy device along BB'.

[0024] Figure 2c It is a schematic structural diagram of a phototherapy device according to a fifth embodiment of the present invention.

[0025] Figure 2d is a cross-sectional view of a phototherapy device according to a sixth embodiment of the present invention (similar to Figure 1a AA' line in the figure).

[0026] Figure 3a It is a schematic diagram of an optical connection structure for connecting a light-conducting component and a light source component according to the present invention.

[0027] Figure 3b It is a schematic diagram of another optical connection structure for connecting a light conducting component and an optical waveguide component according to the present invention.

[0028] Figure 4 is a cross-sectional view of a phototherapy device according to a seventh embodiment of the present invention. DETAILED DESCRIPTION

[0029] The technical solution of the present invention is further described below by specific implementation methods. It should be understood by those skilled in the art that the embodiments are only to help understand the present invention and should not be regarded as specific limitations of the present invention.

[0030] As used herein, "near infrared light" refers to light with a wavelength in the 700-2500nm band. In particular, in the application scenario of phototherapy, "near infrared light" can represent a portion of this band, such as 700-1400nm light. As used herein, "visible light" refers to light with a wavelength in the 400-700nm range. As used herein, "deep red light" refers to light with a wavelength in the 660-700nm range. As used herein, "red light" refers to light with a wavelength in the 600-660nm range.

[0031] As used herein, a wavelength "above" a certain wavelength refers to a wavelength greater than or equal to a certain wavelength, for example, "light above 600nm" refers to light with a wavelength ≥ 600nm. Correspondingly, a wavelength "below" a certain wavelength refers to a wavelength less than (shorter than) equal to a certain wavelength. For example, "light below 400nm" refers to light with a wavelength ≤ 400nm.

[0032] As used herein, "organic small molecule material" refers to any organic or organometallic material that is not a polymer. As long as it has a precise structure, the molecular weight of the small molecule can be very large. Dendritic polymers with a well-defined structure can be considered small molecules. Preferably, the organic small molecule refers to an organic compound with a molecular weight of less than 10,000; more preferably, an organic compound with a molecular weight of less than 5,000; most preferably, an organic compound with a molecular weight of less than 2,000.

[0033] As used herein, "light-conducting component" refers to an optical component that conducts light emitted by a point light source or a line light source from one end of the component to the other end with a loss of no more than 50%, preferably no more than 20%, and more preferably no more than 10%. The light-conducting component may be an optical fiber, or any other component that can achieve total reflection inside a conducting channel.

[0034] As used herein, "optical waveguide component" refers to a component that converts a point light source or a line light source into a surface light source, and its loss is not higher than 90%, preferably, not higher than 70%, and more preferably, not higher than 50%. The optical waveguide component can be a composite structure, for example, comprising an optical waveguide body, a reflective layer, a scattering structure and a combination thereof, or it can be a single-layer structure, for example, nanoparticles with scattering properties are doped into the interior of the optical waveguide body. Preferably, the optical waveguide body is a transparent film layer with a high refractive index. The refractive index of the optical waveguide body is greater than or equal to 1.4, preferably, greater than or equal to 1.45, and more preferably, greater than or equal to 1.49. The optical waveguide body is preferably made of a flexible material. The scattering structure of the optical waveguide component may contain nanoparticles, including but not limited to, SiO x , Al 2 O 3 , CaCO 3 , Ba S O 4 , TiO 2 , oxide particles such as ZrO, ZnO, or metal particles such as Ag, Pt, Cu, Au, or organic particles such as polystyrene microspheres (PS), polymethyl methacrylate (PMMA), silicone, or a combination thereof. The diameter of the nanoparticles should be between 10nm-1000nm, preferably between 100-1000nm, and more preferably between 100-800nm. The scattering structure of the optical waveguide component can be arranged in the form of a film layer on the side of the optical waveguide body away from the reflective layer, or can be doped at intervals inside the optical waveguide body.

[0035] As used herein, "optical coupling" refers to light exiting from one medium and arriving at / entering another medium.

[0036] As used herein, "light emission uniformity of an optical waveguide component" refers to the ratio of light intensity values ​​of any two regions on the entire surface of the optical waveguide component. For example, if the light intensity value of a certain region of the optical waveguide component is A, and the light intensity value of another region is B, then "light emission uniformity" refers to the ratio of A / B. The ratio of A / B is within the range of 1±0.5, preferably within the range of 1±0.3, and more preferably within the range of 1±0.1. When the ratio of A / B is equal to 1 or is closer to 1, the light emission uniformity is better.

[0037] As used herein, "down conversion layer" refers to a film layer that converts high energy light (short wavelength light, such as ultraviolet light, blue light, etc.) into low energy light (long wavelength light, such as red light, deep red light, near infrared light, etc.). The down conversion layer comprises a down conversion material, and the down conversion material includes but is not limited to fluorescent materials, perovskite materials, quantum dot materials, organic small molecule luminescent materials, graphene, etc. The preparation of the "down conversion layer" is already known to those skilled in the art and will not be repeated here.

[0038] As used herein, "encapsulation layer" refers to a film layer having water and oxygen barrier properties, preferably a thin film encapsulation layer. A physical protective film layer (hard coating) may also be provided on the surface of the encapsulation layer to prevent physical scratches and wear.

[0039] As used herein, "negative pressure device" refers to a device that can perform negative pressure suction on a wound, including but not limited to a negative pressure pump, etc.

[0040] According to one embodiment of the present invention, a phototherapy device is disclosed, comprising:

[0041] An electric drive device, a light source component, an optical waveguide component, at least one optical connection structure, and at least one light conducting component;

[0042] Wherein, the light source component is electrically connected to the electric drive device,

[0043] The light source component is connected to the light transmission component,

[0044] The light-conducting component is connected to the light-waveguide component,

[0045] The optical connection structure is arranged between the light source component and the light transmission component, and / or between the light transmission component and the optical waveguide component, and at least one of the optical connection structures enables the two connected components to be detachably separated;

[0046] The optical waveguide component is planar and has at least one light-emitting surface, the area of ​​which is not less than 5 cm 2 .

[0047] Herein, the expression “the optical connection structure is provided between the light source component and the light conduction component, and / or between the light conduction component and the optical waveguide component, and at least one optical connection structure makes the two connected components separable” includes at least the following situations: a first situation, the optical connection structure is provided only between the light source component and the light conduction component, and the light source component and the light conduction component are detachably separable (i.e., the light source component and the light conduction component are detachably connected via the optical connection structure); a second situation, the optical connection structure is provided only between the light conduction component and the optical waveguide component, and the light conduction component and the optical waveguide component are detachably separable (i.e., the light conduction component and the optical waveguide component are detachably connected via the optical connection structure); a third situation, the optical connection structure is provided between the light source component and the light conduction component, and is provided between the light conduction component and the optical waveguide component, and the light source component and the light conduction component are detachably separable, while the light conduction component and the optical waveguide component are detachably separable (i.e., the light source component and the light conduction component are detachably connected via the optical connection structure, while the light conduction component and the optical waveguide component are detachably connected via the optical connection structure).

[0048] According to one embodiment of the present invention, the optical waveguide component is planar and has a light-emitting surface, and the area of ​​the light-emitting surface is not less than 5 cm 2 .

[0049] According to an embodiment of the present invention, the optical connection structure comprises a hole, and the light transmission component is inserted into the hole; preferably, the optical connection structure further comprises a spring sheet, a buckle, a rubber ring or a combination thereof. In some embodiments, the detachable optical connection structure is a first optical connection structure, which is disposed between the light source component and the light transmission component and makes the light source component and the light transmission component detachable.

[0050] According to one embodiment of the present invention, the phototherapy device further comprises a second optical connection structure, which is disposed between the light-conducting component and the optical waveguide component and makes the connection thereof irreversible; preferably, the second optical connection structure comprises optical glue.

[0051] In the present invention, the connection performed by using optical adhesive is a fixed connection, and the connection is irreversible, that is, it cannot be easily disassembled and separated.

[0052] According to an embodiment of the present invention, the optical waveguide component comprises an optical waveguide body, and the optical waveguide component is flexible; preferably, the optical waveguide component has a three-dimensional structure.

[0053] According to an embodiment of the present invention, the material of the optical waveguide body includes a transparent material with a high refractive index.

[0054] According to an embodiment of the present invention, the refractive index of the transparent material is greater than or equal to 1.4.

[0055] According to an embodiment of the present invention, the refractive index of the transparent material is greater than or equal to 1.49.

[0056] According to one embodiment of the present invention, the material of the optical waveguide body includes any one of flexible glass, silicone, PET (polyethylene terephthalate), PEN (polyethylene naphthalate), PMMA (polymethyl methacrylate), and PI (polyimide).

[0057] According to an embodiment of the present invention, the optical waveguide body is an optical waveguide having a grating structure on its surface.

[0058] According to an embodiment of the present invention, the optical waveguide component further comprises a scattering structure.

[0059] According to an embodiment of the present invention, the scattering structure includes a scattering layer and / or scattering points.

[0060] According to an embodiment of the present invention, the scattering structure includes nanoparticles. In some specific embodiments, the scattering layer includes nanoparticles. The scattering points include nanoparticles.

[0061] According to one embodiment of the present invention, the nanoparticles include oxide particles, metal particles, organic particles, or a combination thereof.

[0062] According to one embodiment of the present invention, the oxide particles include SiO x , Al 2 O 3 , CaCO 3 ,BaSO 4 , TiO 2 , ZrO, ZnO. The metal particles include one or more of Ag, Pt, Cu, Au. The organic particles include one or more of polystyrene microspheres, polymethyl methacrylate, and silica gel.

[0063] According to an embodiment of the present invention, the diameter of the nanoparticles is between 10 nm and 1000 nm.

[0064] According to one embodiment of the present invention, the diameter of the nanoparticles is between 100-1000 nm.

[0065] According to one embodiment of the present invention, the diameter of the nanoparticles is between 100-800 nm.

[0066] According to an embodiment of the present invention, the scattering structure is arranged on one side or inside the optical waveguide body, or a combination thereof.

[0067] According to an embodiment of the present invention, the optical waveguide component further comprises a reflective layer, and the reflective layer is arranged on a side of the optical waveguide body away from the site to be treated.

[0068] According to an embodiment of the present invention, the reflective layer is a film layer with high reflectivity.

[0069] According to an embodiment of the present invention, the reflectivity of the film layer is greater than or equal to 50%.

[0070] According to an embodiment of the present invention, the reflectivity of the film layer is greater than or equal to 70%.

[0071] According to an embodiment of the present invention, the reflectivity of the film layer is greater than or equal to 90%.

[0072] According to an embodiment of the present invention, the reflective layer includes any one or more of a metal reflective layer, a metal oxide reflective layer, and a non-metal reflective layer.

[0073] According to an embodiment of the present invention, the metal reflective layer includes a metal thin film layer such as silver, aluminum, copper, etc.

[0074] According to an embodiment of the present invention, the metal oxide reflective layer includes a metal oxide thin film layer formed by any one or more of titanium dioxide, tin oxide, indium oxide, and zinc oxide.

[0075] According to an embodiment of the present invention, the non-metallic reflective layer includes a non-metallic film layer composed of any one or two of carbon, magnesium fluoride, and magnesium dysprosium fluoride.

[0076] According to an embodiment of the present invention, the scattering layer comprises particles or nanowires.

[0077] According to an embodiment of the present invention, the material of the light-conducting component includes optical fiber.

[0078] According to an embodiment of the present invention, the light source component includes at least one LED lamp bead, at least one laser, or at least one OLED.

[0079] According to an embodiment of the present invention, the light source component includes a plurality of light emitting devices; the peak wavelengths of light emitted by the plurality of light emitting devices are the same or different.

[0080] According to an embodiment of the present invention, the light source component comprises two light emitting devices. Preferably, the peak wavelengths of the lights emitted by the two light emitting devices differ by 50 nm or more.

[0081] According to one embodiment of the present invention, the peak wavelengths of the lights emitted by the two light-emitting devices differ by 50 nm, 100 nm, 200 nm, 300 nm, 400 nm, 500 nm, 600 nm or 700 nm.

[0082] According to an embodiment of the present invention, the peak wavelength of the light emitted by the light source component is in the range of 400-1400 nm.

[0083] According to an embodiment of the present invention, the peak wavelength of the light emitted by the light source component is in the range of 600-1400 nm.

[0084] According to an embodiment of the present invention, the peak wavelength of the light emitted by the light source component is within the range of 400-500 nm, and the optical waveguide component further comprises a down-conversion layer, which is arranged on a side of the optical waveguide body close to the site to be treated.

[0085] According to an embodiment of the present invention, the material of the lower conversion layer includes one or more of fluorescent materials, perovskite materials, quantum dot materials, organic small molecule light-emitting materials, and graphene.

[0086] According to one embodiment of the present invention, the optical waveguide component includes, from top to bottom, stacked reflective layers, an optical waveguide body, a scattering structure and a down-conversion layer.

[0087] According to an embodiment of the present invention, the optical waveguide component comprises, from top to bottom, a stacked reflection layer, an optical waveguide body and a down-conversion layer, wherein a scattering structure (eg, a scattering point) is arranged inside the optical waveguide body.

[0088] According to an embodiment of the present invention, the light therapy device comprises two or more light transmission components and / or two or more optical connection structures.

[0089] According to an embodiment of the present invention, the phototherapy device further comprises a skin-friendly layer, and the skin-friendly layer is arranged on a side of the optical waveguide component close to the site to be treated.

[0090] According to an embodiment of the present invention, the material of the skin-friendly layer includes any one of cotton, silk, linen, yarn, and medical silicone. Preferably, the material of the skin-friendly layer is transparent medical silicone.

[0091] According to one embodiment of the present invention, the light emitting area of ​​the optical waveguide component is not less than 10 cm 2 .

[0092] According to one embodiment of the present invention, the light emitting area of ​​the optical waveguide component is not less than 20 cm 2 .

[0093] According to an embodiment of the present invention, the light emission uniformity of the optical waveguide component is within the range of 1±0.5.

[0094] According to an embodiment of the present invention, the light emission uniformity of the optical waveguide component is within the range of 1±0.3.

[0095] According to an embodiment of the present invention, the light emission uniformity of the optical waveguide component is within the range of 1±0.1.

[0096] According to an embodiment of the present invention, the light therapy device further comprises a housing, and the light source component and the electric driving device are integrated in the housing.

[0097] According to one embodiment of the present invention, the light therapy device further comprises a flexible shell, and the optical waveguide component is arranged on the flexible shell.

[0098] According to one embodiment of the present invention, the phototherapy device further includes a negative pressure device, and the negative pressure device is connected to the phototherapy device so that the negative pressure device and the phototherapy device can work individually or simultaneously to achieve treatment.

[0099] According to one embodiment of the present invention, the light source component is connected to the light transmission component, the light transmission component is connected to the optical waveguide component, the light emitted by the light source component passes through the light transmission component and enters from the edge of the optical waveguide component, and the phototherapy device further comprises an absorption layer, a negative pressure giving layer, a negative pressure pump component and a negative pressure pipeline, the negative pressure pump component is connected to the negative pressure pipeline, the negative pressure giving layer is provided with a negative pressure pipeline, the absorption layer is provided between the negative pressure giving layer and the part to be treated, the optical waveguide component is provided between the absorption layer and the part to be treated, and the optical waveguide component is provided with at least one channel penetrating the upper and lower surfaces thereof. In order to achieve negative pressure treatment of the part to be treated during phototherapy, so that pus or blood in the part to be treated can enter the absorption layer through the penetrating channel; increase blood flow in the blood vessels of the wound surface, stimulate the growth of granulation tissue, fully drain exudate, reduce edema, resist infection, and accelerate wound healing.

[0100] According to one embodiment of the present invention, the optical waveguide component has a first surface, a second surface opposite to the first surface, and a side surface between the first surface and the second surface, the light conduction component is connected to the side surface of the optical waveguide component, and the light emitted by the light source component passes through the light conduction component and is incident from the side surface of the optical waveguide component.

[0101] According to one embodiment of the present invention, the material of the negative pressure applying layer includes any one of foam material, non-woven material and the like.

[0102] The light source component of the present invention is connected to a light transmission component, such as an optical fiber, to achieve remote light transmission. The light source component is also electrically connected to the electric drive device to obtain the power required for lighting or adjustment. The present invention can use a single light source component or multiple light source components, each of which can be optically coupled to a light transmission component, and all light source components can be driven by an electric drive device. The light source component and the drive device (except the battery) are non-replaceable components (i.e., components that are not replaced during or after use). The light transmission component is optically coupled to the optical waveguide component, where the optical waveguide component can be directly attached to the part to be treated, or can be arranged on a flexible shell with a highly three-dimensional structure, and the optical waveguide component and the flexible shell can be integrally formed, fixedly connected, or detachably connected.

[0103] The optical waveguide component is detachable from the optical conduction component, or the optical conduction component is detachable from the light source, or the optical conduction component is detachable from both the optical waveguide component and the light source. Preferably, the optical conduction component is detachable from the light source.

[0104] The optical waveguide component and / or the flexible shell can be made into the shape of a facial mask, an eye mask, a neck mask, a band-aid, etc. The user wears the optical waveguide component and / or the flexible shell on the part to be treated, and uses the electric drive device to light up the light source component. The high-energy light (such as blue light) emitted by the light source component enters the optical waveguide component through the light-conducting component, and through the internal reflection, scattering, and down-conversion mechanism, it is evenly emitted from the surface of the optical waveguide component and / or the flexible shell to the part to be treated in the form of low-energy light (such as red light). In this way, the optical waveguide component and / or the flexible shell can be made to completely fit the part to be treated, thereby enhancing the treatment effect. Of course, the phototherapy device of the present invention can also directly use a point light source or a line light source that emits red light with a peak wavelength of 600nm or above, so that it can be used directly without setting a down-conversion layer.

[0105] The present invention will be further described below in conjunction with specific implementation schemes, but the present invention is not limited thereto.

[0106] In a first embodiment of the present invention, reference is made to Figure 1aThe phototherapy device 100 includes a light source component 101, a light transmission component 102, an optical waveguide component 103, an electric driving device 104, and an optical connection structure 105. The light source component 101 is optically coupled to the light transmission component 102 via the optical connection structure 105. The light source component 101 can be a point light source, a line light source, or a surface light source. Preferably, the light source component 101 includes but is not limited to LED lamp beads, lasers or OLEDs. Preferably, the light source component 101 includes LED lamp beads or lasers. The special phototherapy device in the present invention can convert a point light source or a line light source into a surface light source even when using LED lamp beads or lasers, thereby enabling large-area treatment without being limited to more expensive OLEDs.

[0107] The light source component 101 emits light with a peak wavelength of 400-1400nm. Preferably, the light source component 101 emits blue light with a peak wavelength of 400-480nm, or red light, deep red light and near infrared light with a peak wavelength of 600-1400nm. The light source component 101 may include multiple light-emitting devices, for example, multiple LED lamp beads. Preferably, multiple LED lamp beads can emit light of different colors. For example, at least one LED lamp bead emits red light and deep red light with a peak wavelength of 600-700nm, and at least another LED lamp bead emits near infrared light with a peak wavelength of 700-1400nm. The light source component 101 is connected to the electric drive device 104 through an electrical connector 1041. The electrical connector 1041 includes but is not limited to one or more of thin film metal, transparent conductive material, and FPC lead. The electric drive device 104 includes but is not limited to one or more of a power supply, a charging device (preferably a wireless charging device), a Bluetooth communication device, a chip, a lead, a circuit board, a switch and other devices. The power source includes a battery, and the battery can be selected from one or more of a thin film battery, a micro battery, a button battery, a chemical battery, a lithium battery, and a hydrogen battery. The electric drive device can also be wirelessly connected to an external electronic device via a Bluetooth communication device, and controlled by the external electronic device, such as switching, brightness adjustment, and partition control, for example, only lighting up the red light emitting device, or lighting up the red light emitting device and the near-infrared light emitting device at the same time. The external electronic device can be a smart phone, a smart watch, a tablet computer, a laptop computer, and other devices. Furthermore, the external electronic device can also be controlled in conjunction with an application (APP). Although Figure 1a In the figure, the electric driving device 104 and the light source component 101 are drawn as two independent components, but these two components (including the electrical connector 1041) can be arranged in a housing as a whole, such as Figure 3aThe housing 306 is shown. When in use, the light source component 101 and the electric drive device 104 do not need to be replaced. If the two are in one housing, the entire housing does not need to be replaced. An optical connection structure 1051 may also be provided between the light transmission component 102 and the optical waveguide component 103, and the structure allows the light emitted by the light transmission component 102 to be coupled with the optical waveguide component 103. The optical connection structure 1051 can make the light transmission component 102 and the optical waveguide component 103 easy to disassemble and separate, and can also fix the two.

[0108] An example of an optical connection structure for connecting a light transmission component and a light source component is shown in FIG. Figure 3a As shown, at this time, multiple light source components 301 are connected to the electric drive device 304 through the electrical connector 3041 and are installed together in the housing 306. The light transmission component 302 is inserted through the reserved hole 305 and directly contacts the light source component 301. At this time, the light emitted by the light source component 301 can be optically coupled with the light transmission component 302, and the reserved hole 305 is an optical connection structure. In order to fix the light transmission component 302, the hole 305 (i.e., the optical connection structure) can also include a fixing device 3050, including but not limited to a spring sheet, a buckle, a rubber ring, etc. At this time, the light source component 301 and the light transmission component 302 can be easily disassembled. For example, the separation of the two can be achieved by simply pulling the light transmission component 302 out of the hole 305. As shown in FIG. Figure 3a The optical connection structure 300 shown can also be used to connect the light-conducting component and the optical waveguide component, that is, a hole is opened in the optical waveguide component, and then the light-conducting component 302 is directly inserted, and this method can realize the separation of the light-conducting component and the optical waveguide component. Another example of an optical connection structure for connecting the light-conducting component and the optical waveguide component is shown in FIG. Figure 3b As shown, the light transmission component 312 is connected to the light waveguide component 313 by an optical glue 315. At this time, the optical glue is an optical connection structure, and the connection between the light transmission component 312 and the light waveguide component 313 is irreversible, and the two cannot be easily separated. The optical connection structure of the present invention is not limited to the above situation. Any structure known in the prior art that can be used to connect the light source component and the light transmission component, or the structure that can be used to connect the light transmission component and the light waveguide component can be used in the present invention. The above situation is only an example.

[0109] exist Figure 1b In the light therapy device 110 of the second embodiment of the present invention, the light source component 111 is electrically connected to the electric driving device 114 through the electrical connector 1141. When the light source component 111 includes a plurality of light emitting devices with different colors, each light emitting device can be independently connected to a light transmission component. Figure 1bIn the phototherapy device 110 shown, the light source component 111 includes a plurality of light-emitting devices (not shown in the figure), each of which is optically coupled to independent light-conducting components 1121 and 1122 via an optical connection structure 1150, and optically connected to the optical waveguide component 113 via optical connection structures 1151 and 1152.

[0110] In a third embodiment of the present invention, Figure 1c In the phototherapy device 120 shown, the light source component 121 is electrically connected to the electric driving device 124 via an electrical connector 1241. Multiple light emitting devices of the same color on the light source component 121 can be optically coupled to the same light conducting component main component 122 via an optical connecting structure 1250, and connected to different positions of the optical waveguide component 123 via light conducting component branch lines 1221 and 1222 and optical connecting structures 1251, 1252 and 1253.

[0111] In a fourth embodiment of the present invention, Figure 1b and Figure 1c The two methods are combined to form Figure 1d In the phototherapy device 130 shown, the light source component 131 is electrically connected to the electric driving device 134 through the electrical connection component 1341. The light source component 131 has a plurality of light emitting devices, which are optically coupled to the main light transmission components 1321 and 1322 through the optical connection structure 1350, and then branch lines 13211, 13212, 13221 and 13222 are branched out, and optically coupled to the optical waveguide component 133 through the optical connection structures 1351, 1352, 1353, 1354, 1355 and 1356.

[0112] like Figure 1b-1d The advantage of the phototherapy device shown is that it can increase the incident light energy in the optical waveguide to improve the light intensity. At the same time, it can also increase the uniformity of the output light by setting the light incident at multiple points. The electric drive devices 114, 124 and 134 can also achieve brightness control, color control, etc. by selecting different light-emitting devices to achieve different treatment effects. It should be understood that although the optical connectors are all in the form of dots in the figure, they can also be linear, which is not drawn here.

[0113] Figure 2a Shows Figure 1aIn the cross-sectional view 200 of the phototherapy device 100 along the AA' line, the light source component 201 is connected to the electric driving device 204 through the electrical connector 2041, and is optically coupled to the light transmission component 202 through the optical connection structure 2050. The light transmission component 202 is further optically coupled to the optical waveguide component 203 through the optical connection structure 2051. The light emitted by the light source component 201 is emitted from one side of the optical waveguide component 203 after various levels of transmission, as shown by the arrow in the figure, and the emission direction points to the part to be treated. The light transmission component 202 can transmit light energy from one end to the other end with low loss or even nearly lossless, and the loss is not higher than 50%, preferably, not higher than 20%, and more preferably, not higher than 10%. The light transmission component 202 is preferably an optical fiber. Generally, total reflection occurs when light propagates in the optical fiber, so it can be transmitted from one end to the other end almost losslessly. It should be understood that any tubular or sheet-like component that can form total reflection of the internal light path can be used as a light transmission component. The light source component 201 and the light transmission component 202 are optically coupled via the optical connection structure 2050, that is, the light emitted by the light source 201 is transmitted to the light transmission component 202. As mentioned above, the optical connection structures 2050 and 2051 at both ends of the light transmission component 202 can be disassembled and separated from the light source and / or the optical waveguide, preferably, disassembled and separated from the light source. The light transmission component 202 and the optical connection structures 2050 and 2051 are well known to those skilled in the art and will not be described in detail here. The optical waveguide component 203 is planar, and its light emitting area is not less than 5 cm 2 , preferably, not less than 10cm 2 , more preferably, not less than 20cm 2 The optical waveguide component 203 is flexible and includes a curved surface. Figure 2a The optical waveguide component 203 is curved along two sides of an axis perpendicular to the AA' line, but it should be understood that the optical waveguide component 203 can be any curved surface, such as Figure 2b The optical waveguide component 213 shown is bent along both sides of the axis perpendicular to the BB' line. Preferably, the optical waveguide component 203 is a three-dimensional structure designed according to the part to be treated and can fit tightly with the part to be treated. The optical waveguide component 203 can be used directly as a phototherapy device. Preferably, the optical waveguide component 203 can be set on a flexible shell, so that the overall appearance can be more beautiful. The optical waveguide component 203 in the present invention can convert the incident point light source or line light source into a surface light source for emission, and by reasonably setting the structure, such as adding a scattering structure, etc., a uniform ground light source can be emitted. The uniformity of the light emitted by the optical waveguide component 203 refers to the ratio of the light intensity values ​​of any two areas on the surface of the entire optical waveguide component. The uniformity of the light emitted by the optical waveguide component 203 is within the range of 1±0.5, preferably within the range of 1±0.3, and more preferably within the range of 1±0.1.

[0114] Figure 2b Shows Figure 1b In the cross-sectional view 210 of the phototherapy device 110 along BB', the light source component 211 is electrically connected to the electric driving device 214 through the electrical connector 2141, and is optically coupled with the light transmission components 2121 and 2122 through the optical connection structure 2150, and is further optically connected to the optical waveguide component 213 through the optical connection structures 2151 and 2152, and is emitted from one side of the optical waveguide component 213. Figure 2b The optical waveguide component 213 can be further divided into several components, including but not limited to an optical waveguide body 2131, a reflective layer 2132 and a scattering layer 2133 (i.e., a scattering structure). The reflective layer 2132 is arranged on the side of the optical waveguide body 2131 away from the part to be treated; the scattering layer 2133 is arranged on the side of the optical waveguide body 2131 close to the part to be treated. The optical waveguide body 2131 can be a transparent material with a high refractive index, and the refractive index is greater than or equal to 1.4, preferably, greater than or equal to 1.45, and more preferably, greater than or equal to 1.49. The material of the optical waveguide body 2131 includes but is not limited to flexible glass, silicone (Silicon), PET, PEN, PMMA, PI, etc. The optical waveguide body 2131 can also be an optical waveguide with a grating structure on the surface. The reflective layer 2132 can be a film layer with a high reflectivity, and the reflectivity is greater than or equal to 50%, preferably, greater than or equal to 70%, and more preferably, the reflectivity is greater than or equal to 90%. The reflective layer 2132 may include any one or more of a metal reflective layer, a metal oxide reflective layer, and a non-metal reflective layer. The metal reflective layer may include a metal thin film layer of silver, aluminum, copper, etc. The metal oxide reflective layer may include a metal oxide thin film layer formed by any one or more of titanium dioxide, tin oxide, indium oxide, and zinc oxide. The non-metal reflective layer may include a non-metal film layer composed of any one or two of carbon, magnesium fluoride, and magnesium dysprosium fluoride. The scattering layer 2133 may be a transparent film layer doped with scattering nanoparticles, or it may be a micro-nano structure formed on the surface of the optical waveguide body 2131 to achieve scattering. The material of the transparent film layer in the scattering layer may include various organic macromolecular polymers, including but not limited to PMMA, PET, PEN, PI, etc. The scattering layer 2133 may contain nanoparticles, including but not limited to SiO x , Al 2 O 3 , CaCO 3 ,BaSO 4 , TiO 2, ZrO, ZnO and other oxide particles, or Ag, Pt, Cu, Au and other metal particles, or polystyrene microspheres (PS), polymethyl methacrylate (PMMA), silica gel and other organic particles, or a combination thereof. The diameter of the nanoparticles should be between 10nm-1000nm, preferably between 100-1000nm, and more preferably between 100-800nm. Scattering points can be further added to the optical waveguide component 213, such as Figure 2b The scattering structures 21330 are distributed at intervals throughout the optical waveguide body 2131. When the optical waveguide material is an organic material, scattering nanoparticles can be injected into a specified area before the optical waveguide material is solidified during the preparation process to achieve scattering points. Alternatively, an organic material with the same refractive index can be poured between multiple optical waveguide units, and scattering nanoparticles can be added therein, and then solidified to achieve regionalized scattering points. The scattering layer 2133 and the scattering points 21330 are collectively referred to as scattering structures, which can be used separately or in combination. The material of the scattering points is the same as or different from that of the scattering layer, including but not limited to SiO x , Al 2 O 3 , CaCO 3 ,BaSO 4 , TiO 2 , oxides such as ZrO, ZnO, or metals such as Ag, Pt, Cu, Au, or organic substances such as polystyrene microspheres (PS), polymethyl methacrylate (PMMA), silica gel (Silicon), or a combination thereof.

[0115] In some specific embodiments, the reflective layer can be prepared on the optical waveguide body by metal sputtering, thermal evaporation, etc., or by coating the optical waveguide body with metal particles or nanowires, including but not limited to silver paste, copper paste, silver nanowires, carbon nanowires, etc., dissolved in a solution method. The scattering layer can also be prepared by a solution method, firstly dissolving the nanoparticles uniformly in a matrix, which can be various organic macromolecular polymers, and then coating it on the optical waveguide body.

[0116] In a fifth embodiment of the present invention, reference Figure 2cIn the phototherapy device 220, the light source component 221 is electrically connected to the electric driving device 224 through the electrical connector 2241, and is optically coupled to the light transmission components 2221 and 2222 through the optical connection structure 2250, and is further optically connected to the optical waveguide component 223 through the optical connection structures 2251 and 2252, and is emitted from one side of the optical waveguide component 223. The optical waveguide component 223 may also include an optical waveguide body 2231 and a reflective layer 2232, and the scattering structure is uniformly doped in the optical waveguide body 2231 in the form of nanoparticles to achieve scattering so that the point light source or line light source transmitted from the optical connection structures 2251 and 2252 is emitted in the form of a surface light source (as shown by the arrow in the figure). Note that the nanoparticles can be evenly distributed in the body of the optical waveguide component or can be concentrated in individual areas. For example, scattering nanoparticles can be doped into an organic polymer material used to prepare an optical waveguide body, and the doped material (such as silica gel doped with scattering nanoparticles) can be molded to form an optical waveguide body having scattering properties. In this case, a scattering layer can be omitted.

[0117] In a sixth embodiment of the present invention, Figure 2d A cross-sectional view of a light therapy device 230 is shown (similar to Figure 1aAA' cross-sectional view), wherein the light source component 231 is connected to the electric drive device 234 through the electrical connector 2341, and the light source component 231 here includes at least one light-emitting device (such as an LED lamp bead or a laser), which emits blue light with a peak wavelength of 400-500nm. When the light beam is optically coupled with the light transmission component 232 through the optical connection structure 2350, and further reaches the optical waveguide component 233 through the optical connection structure 2351, it will be converted into a surface light source and emitted from one side of the optical waveguide component 233, as shown by the arrow in the figure. At this time, a down-conversion layer 2330 is also arranged on the exit surface (i.e., the surface close to the part to be treated) of the optical waveguide component 233. The down-conversion layer 2330 has an absorption peak and an emission peak, and its absorption peak is within the range of + / -20nm of the peak wavelength of the exit light of the light source component 231, and its emission peak is within the range of +100nm and above of the peak wavelength of the exit light of the light source component 231. Preferably, the emission peak of the lower conversion layer 2330 is at or above 600nm. The material of the lower conversion layer 2330 may include but is not limited to fluorescent materials, perovskite materials, quantum dot materials, organic small molecule luminescent materials, graphene, etc. In order to ensure that the lower conversion layer 2330 is not invaded by water and oxygen, an encapsulation layer (not shown in the figure) may be provided between the lower conversion layer 2330 and the part to be treated (i.e., on the side of the lower conversion layer 2330 away from the optical waveguide component 233). The lower conversion layer may also be provided between the reflective layer of the optical waveguide component 233 and the optical waveguide body, in which case an encapsulation layer is not required. The lower conversion layer may also be prepared using a solution method, where the lower conversion material is dissolved in a solvent and then coated on one side of the optical waveguide component, and then cured into a film. It should be noted that, although not shown in the figure, a skin-friendly layer can be further arranged between the optical waveguide component (including the down-conversion layer and the encapsulation layer) and the part to be treated. The material can be selected from a mesh fabric composed of natural cotton, silk, linen, etc. to ensure light transmittance; it can also be a transparent material such as medical silicone, preferably transparent medical silicone. The entire optical waveguide component and other film layers can be prepared and cured by a solution method, and a layer of optical glue can be coated between different film layers for fixation. In another embodiment, the entire optical waveguide component and other film layers can be further integrated on a housing, and the film layers can be fixed together by the structural design on the housing.

[0118] In a seventh embodiment of the present invention, Figure 4The figure shows a cross-sectional schematic diagram of a phototherapy device 410, in which a light source component 411 is disposed outside an optical waveguide component 412, is electrically connected to an electric drive device 414 via an electrical connector 4141, and is optically coupled to an optical transmission component 418 via an optical connection structure 4190. The optical transmission component 418 transmits light to the other end and is optically coupled to the optical waveguide component 412 via optical connection structures 4191 and 4192, and finally emits light from one side of the optical waveguide component 412 in the form of a surface light source. As shown by the arrow in the figure, the light emission direction of the light-emitting surface points to the part to be treated. An absorption layer 413, a negative pressure imparting layer 415, and a negative pressure pump component 416 connected via a negative pressure pipe 417 are further provided on the optical waveguide component 412, and a series of channels 4120 (channels 4120 run through the entire optical waveguide component 412) are also provided on the optical waveguide component 412 to ensure that the negative pressure can be transmitted to the part to be treated and that the liquid can be absorbed by the absorption layer 413 through the channels 4120. The optical transmission component 418 can transmit light energy from one end to the other end with low loss or even nearly lossless, with a loss of no more than 50%, preferably no more than 20%, and more preferably no more than 10%. The optical transmission component 418 is preferably an optical fiber, and generally, total reflection occurs when light propagates in the optical fiber, so that it can be transmitted from one end to the other end almost losslessly. It should be understood that any tubular or sheet-like component that can form total reflection of the internal light path can be used as the optical transmission component. The light source component 411 and the light transmission component 418 are optically coupled via the optical connection structure 4190, that is, the light emitted by the light source component 411 is transmitted to the light transmission component 418. Similarly, the light at the other end of the light transmission component 418 can be optically coupled to the optical waveguide component 412 via the optical connection structures 4191 and 4192. Note that at this time, the light source component 411 and the electric drive device 414 can be arranged in the same housing. Preferably, the negative pressure pump component 416 can share an electric drive device 414 with the light source component 411 and be arranged in the same housing. The light transmission component 418 can be close to the negative pressure pipe 417, making the entire device more concise and beautiful. It should be noted that although only one light source component 411 is drawn in the figure, it can include multiple light-emitting devices, and each light-emitting device can also have its own corresponding light transmission component.

[0119] Figure 4The absorption layer 413 is mainly used to absorb other liquids such as blood and pus, and its material includes but is not limited to gauze, cotton cloth, non-woven fabrics, bamboo fiber, pulp and combinations thereof. The negative pressure pump component 416 includes a micro pump for generating negative pressure, and is connected to the negative pressure giving layer 415 through a negative pressure pipe 417. The negative pressure giving layer 415 provides physical support for the negative pressure pipe 417, so that the negative pressure pipe 417 can be directly attached to the absorption layer 413 and aim at the area to be treated to draw air. The negative pressure giving layer 415 can further include a series (at least one) of micro pipes and channels connected to the outlet of the negative pressure pipe 417, so that the negative pressure can be evenly distributed throughout the area to be treated, improving the treatment effect. The negative pressure pump component 416 can also include a collecting component (the collecting component is connected to the negative pressure pipe 417, and is no longer drawn in the figure), which can absorb those liquids or solids that pass through the absorption layer 413. Figure 4 The phototherapy device may further include a filter layer (not shown in the figure) between the absorption layer 413 and the negative pressure providing layer 415, and the filter layer may block some solid matter to avoid blocking the negative pressure pipe 417 and contaminating the negative pressure pump component 416. The negative pressure pump component 416 also includes an electric drive device (not shown in the figure) for driving the pump. Preferably, the electric drive device of the negative pressure pump component 416 and the electric drive device 414 of the light source component 411 may be the same electric drive device. Figure 4 The phototherapy device can turn on the negative pressure pump component to perform negative pressure healing treatment on the wound. At the same time, it can also turn on the light source component and form a light-emitting surface through the optical waveguide component to perform phototherapy on the wound, accelerate wound healing and fade scars.

[0120] Generally, the optical waveguide component can be made of materials such as plastic and silicone. Preferably, the optical waveguide component is a flexible material and has a low preparation cost. It is also easy to integrate different film layers, doped nanomaterials, etc. during the preparation process. Most importantly, the optical waveguide component can be formed in a pre-cast model to achieve a three-dimensional structure that can better fit human skin. Down-conversion materials are usually also low-cost and can be prepared using a solution method to match the flexible preparation process. Therefore, both parts can achieve low cost and high fit. Since the optical connection structure is detachable, the optical waveguide components and the like are disposable, which can also ensure hygiene and avoid cross infection.

[0121] The phototherapy device of the present invention adopts a planar optical waveguide component, which can convert a point light source or a line light source into a planar light source, thereby realizing large-area treatment. In addition, since the light source component is not integrated on the optical waveguide component, the planar optical waveguide component can realize a highly three-dimensional structure and better fit the part to be treated. At the same time, since the component contacting the part to be treated can be prepared at low cost and can be separated from the light source, the component can be directly discarded after use, which improves hygiene and avoids cross infection.

[0122] It should be understood that the various embodiments described herein are only examples and are not intended to limit the scope of the present invention. Therefore, as will be apparent to those skilled in the art, the claimed invention may include variations of the specific embodiments and preferred embodiments described herein. Many of the materials and structures described herein may be replaced with other materials and structures without departing from the spirit of the present invention. It should be understood that the various theories about why the present invention works are not intended to be restrictive.

Claims

1. A phototherapy device, comprising: An electric drive device, a light source component, an optical waveguide component, at least one optical connection structure, and at least one light conducting component; in, The light source component is electrically connected to the electric drive device, The light source component is connected to the light transmission component, The light-conducting component is connected to the light-waveguide component, The optical connection structure is arranged between the light source component and the light transmission component, and / or between the light transmission component and the optical waveguide component, and at least one of the optical connection structures enables the two connected components to be detachably separated; The optical waveguide component is planar and has at least one light-emitting surface, the area of ​​which is not less than 5 cm 2 .

2. The phototherapy device according to claim 1, It is characterized in that The optical connection structure comprises a hole, and the light-conducting component is inserted into the hole; preferably, the optical connection structure further comprises a spring sheet, a buckle, a rubber ring or a combination thereof.

3. The phototherapy device according to claim 1, It is characterized in that It also includes a second optical connection structure, which is arranged between the light-conducting component and the optical waveguide component and makes the connection irreversible; preferably, the second optical connection structure includes optical glue.

4. A phototherapy device according to any one of claims 1 to 3, It is characterized in that The optical waveguide component comprises an optical waveguide body, and the optical waveguide component is flexible; preferably, the optical waveguide component has a three-dimensional structure.

5. The phototherapy device according to claim 4, It is characterized in that The material of the optical waveguide body includes a transparent material with a high refractive index; the refractive index of the transparent material is greater than or equal to 1.4, preferably, greater than or equal to 1.49; preferably, the material of the optical waveguide body includes any one of flexible glass, silicone, PET, PEN, PMMA, and PI; or, the optical waveguide body is an optical waveguide with a grating structure on the surface.

6. The phototherapy device according to claim 4, It is characterized in that The optical waveguide component further comprises a scattering structure; preferably, the scattering structure comprises a scattering layer and / or scattering points; preferably, the scattering structure comprises nanoparticles; preferably, the nanoparticles comprise oxide particles, metal particles, organic particles, or a combination thereof; preferably, the oxide particles comprise SiO x , Al 2 O 3 , CaCO 3 ,BaSO 4 , TiO 2 , one or more of ZrO, ZnO, the metal particles include one or more of Ag, Pt, Cu, Au, the organic particles include one or more of polystyrene microspheres, polymethyl methacrylate, silica gel; preferably, the diameter of the nanoparticles is between 10nm-1000nm, preferably, between 100-1000nm, more preferably, between 100-800nm.

7. The phototherapy device according to claim 6, It is characterized in that The scattering structure is arranged on one side or inside the optical waveguide body or a combination thereof.

8. The phototherapy device according to claim 4, It is characterized in that The optical waveguide component further includes a reflective layer, which is disposed on a side of the optical waveguide body away from a site to be treated.

9. The phototherapy device according to claim 8, It is characterized in that The reflective layer is a film layer with high reflectivity; the reflectivity of the film layer is greater than or equal to 50%, preferably, greater than or equal to 70%, and more preferably, greater than or equal to 90%; preferably, the reflective layer includes any one or more of a metal reflective layer, a metal oxide reflective layer, and a non-metallic reflective layer.

10. The phototherapy device according to claim 1, It is characterized in that The material of the light-conducting component includes optical fiber.

11. A phototherapy device according to any one of claims 1 to 3, It is characterized in that The light source component includes at least one LED lamp bead, at least one laser, or at least one OLED.

12. The light therapy device according to claim 11, It is characterized in that The light source component includes two light emitting devices. Preferably, the peak wavelengths of the lights emitted by the two light emitting devices differ by 50 nm or more.

13. A phototherapy device according to any one of claims 1 to 3, It is characterized in that The peak wavelength of the light emitted by the light source component is within the range of 400-1400nm; preferably, the peak wavelength of the light emitted by the light source component is within the range of 600-1400nm.

14. The light therapy device according to claim 11, It is characterized in that The peak wavelength of the light emitted by the light source component is in the range of 400-500nm, and the optical waveguide component further comprises a down-conversion layer, which is arranged on a side of the optical waveguide body close to the part to be treated; preferably, the material of the down-conversion layer includes one or more of fluorescent materials, perovskite materials, quantum dot materials, organic small molecule luminescent materials, and graphene.

15. The light therapy device according to claim 1, It is characterized in that Contains two or more of the light-conducting components, and / or two or more of the optical connecting structures.

16. The light therapy device according to claim 1, It is characterized in that It further comprises a skin-friendly layer, which is arranged on a side of the optical waveguide component close to the part to be treated; preferably, the material of the skin-friendly layer includes any one of cotton, silk, linen, gauze, and medical silicone; preferably, the material of the skin-friendly layer is transparent medical silicone.

17. The light therapy device according to claim 1, It is characterized in that The light emitting area of ​​the optical waveguide component is not less than 10cm 2 , preferably, not less than 20cm 2 .

18. The light therapy device according to claim 1, It is characterized in that The light emission uniformity of the optical waveguide component is within the range of 1±0.5, preferably, within the range of 1±0.3, and more preferably, within the range of 1±0.

1.

19. The light therapy device according to claim 1, It is characterized in that The invention further comprises a housing, wherein the light source component and the electric driving device are integrated in the housing.

20. The light therapy device of claim 1, It is characterized in that The invention further comprises a flexible housing, wherein the optical waveguide component is arranged on the flexible housing.

21. The light therapy device of claim 1, It is characterized in that It further comprises a negative pressure device, which is connected to a phototherapy device so that the negative pressure device and the phototherapy device can work individually or simultaneously to achieve treatment.